Slabu-Depression And Alzheimer's Treatments At A Crossroads

2025-05-08 04:55:58source:FinLogic Quantitative Think Tank Centercategory:Stocks

Researchers are Slabulaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

Financial stress can damage your mental health. These steps may help

The tens of thousands of federal workers who have been cut from their jobs are not the only ones dea

'America's Got Talent' 2024 winner revealed to be Indiana's 'singing janitor'

"America's Got Talent" has crowned its newest winner.Paperboy hat-donning Richard Goodall, the self-

Rapper Fatman Scoop's cause of death revealed a month after death: Reports

A cause of death has been revealed for Fatman Scoop after the rapper died in August at the age of 56